JUPITER NEUROSCIENCES, INC.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
JUNS$2.22+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash | $2,362,749 | $3,789,342 |
| Accounts receivable | - | 2,637 |
| Prepaid contracts | 766,667 | 766,667 |
| Inventory, net | 148,068 | 159,790 |
| Other current assets | 132,696 | 106,542 |
| Total current assets | 3,410,180 | 4,824,978 |
| Operating lease right of use asset, net | 11,607 | 23,214 |
| Prepaid contracts, noncurrent | 523,014 | 712,055 |
| Other assets | 3,783 | 3,783 |
| Total assets | $3,948,584 | $5,564,030 |
| Liabilities and Stockholders’ Deficit | ||
| Current Liabilities: | ||
| Accounts payable and accrued expenses | $474,636 | $638,646 |
| Accrued compensation | 1,422,612 | 1,397,357 |
| Accrued interest | - | 39,829 |
| Deferred revenue | - | 735 |
| Operating lease liability | 8,508 | 21,247 |
| Convertible notes payable, fair value | 4,824,411 | 5,298,068 |
| Refund liability | 1,874 | - |
| Total current liabilities | 6,732,041 | 7,395,882 |
| Total liabilities | 6,732,041 | 7,395,882 |
| Commitments and Contingencies (Note 7) | - | |
| Stockholders’ Deficit: | ||
| Series A preferred stock, par value $0.0001; 5,000,000 shares authorized, nil shares issued and outstanding | - | - |
| Common stock, par value $0.0001; 500,000,000 and 125,000,000 shares authorized, respectively; 36,281,352 and 34,446,455 issued and outstanding, respectively | 3,628 | 3,444 |
| Additional paid in capital | 33,941,899 | 32,831,730 |
| Accumulated deficit | (36,728,984) | (34,667,026) |
| Total stockholders’ deficit | (2,783,457) | (1,831,852) |
| Total liabilities and stockholders’ deficit | $3,948,584 | $5,564,030 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.